New Alzheimer’s disease drug trial opens across Scotland

A new trial, funded by the Efficacy and Mechanism Evaluation (EME) Programme is investigating if a drug normally used to treat high blood pressure (hypertension) has additional properties that could slow down the progression of Alzheimer’s disease in people with and without hypertension. Led by academics from the Universities of Bristol, Cambridge, Queen’s University Belfast,...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news